SEROUS ENDOMETRIAL CANCER

Clinical trials for SEROUS ENDOMETRIAL CANCER explained in plain language.

Never miss a new study

Get alerted when new SEROUS ENDOMETRIAL CANCER trials appear

Sign up with your email to follow new studies for SEROUS ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug combo shows promise for Tough-to-Treat endometrial cancer

Disease control Completed

This study tested a combination of two drugs, pembrolizumab and olaparib, in 26 people with endometrial cancer that came back or didn't go away. The goal was to see if the treatment could shrink tumors and how safe it was. The results help doctors understand if this approach is w…

Matched conditions: SEROUS ENDOMETRIAL CANCER

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Jun 17, 2026 12:03 UTC

SEROUS ENDOMETRIAL CANCER

Get alerted when new SEROUS ENDOMETRIAL CANCER trials appear

New drug combo shows promise for Tough-to-Treat endometrial cancer